Cite
Herrera AF, Palmer J, Adhikarla V, et al. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021;5(23):5300-5311doi: 10.1182/bloodadvances.2021004981.
Herrera, A. F., Palmer, J., Adhikarla, V., Yamauchi, D., Poku, E. K., Bading, J., Yazaki, P., Dandapani, S., Mei, M., Chen, R., Cao, T., Karras, N., McTague, P., Nademanee, A., Popplewell, L., Sahebi, F., Shively, J. E., Simpson, J., Smith, D. L., Song, J., Spielberger, R., Tsai, N. C., Thomas, S. H., Forman, S. J., Colcher, D., Wu, A. M., Wong, J., & Smith, E. (2021). Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood advances, 5(23), 5300-5311. https://doi.org/10.1182/bloodadvances.2021004981
Herrera, Alex F, et al. "Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma." Blood advances vol. 5,23 (2021): 5300-5311. doi: https://doi.org/10.1182/bloodadvances.2021004981
Herrera AF, Palmer J, Adhikarla V, Yamauchi D, Poku EK, Bading J, Yazaki P, Dandapani S, Mei M, Chen R, Cao T, Karras N, McTague P, Nademanee A, Popplewell L, Sahebi F, Shively JE, Simpson J, Smith DL, Song J, Spielberger R, Tsai NC, Thomas SH, Forman SJ, Colcher D, Wu AM, Wong J, Smith E. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021 Dec 14;5(23):5300-5311. doi: 10.1182/bloodadvances.2021004981. PMID: 34638132.
Copy
Download .nbib